Crossmark

ACADL suppresses PD-L1 expression to prevent cancer immune evasion by targeting Hippo/YAP signaling in lung adenocarcinoma

Published Online: 2023-03-17

Authors

Li, Li

Wang, Ling-Ling

Wang, Tao-Li

Zheng, Fei-Meng https://orcid.org/0000-0001-8793-6677
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81602585)

Science and Technology Planning Project of Guangdong Province (2021A1515010124)

Science and Technology Planning Project of Guangdong Province (2017A030313522)

Fundamental Research Funds for the Central Universities (18ykpy13)

Kelin Nova Program of The First Affiliated Hospital of Sun Yat-sen University

Shenzhen Fundamental Research Program (JCYJ2019081280001770)
License Information

Text and Data Mining valid from 2023-03-17

Version of Record valid from 2023-03-17
More Information

Article History

Received: 25 November 2022

Accepted: 17 February 2023

First Online: 17 March 2023

Declarations

:

: The authors declare that they have no conflict(s) of interest in this research.

: Not applicable.

: Not applicable.

Document is current